IPD
IMPEDIMED LIMITED
$0.0060
0.00%
Market cap
$22M
Turnover
$37,846
Last price
$0.0060
Day change
0.00%
Announcements
12
Range, past year
Open 0.045 · Low 0.003 · Now 0.006 · High 0.059
Open IPD in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
IPD momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-10-13.
Momentum quality
33/100
Wyckoff phase
Accumulation8d
Trend stage
Emerging
1 Day
+0.0%
1 Week
+0.0%
1 Month
+20.0%
1 Year
-87.0%
RSI
55
Avg daily range
16.7%
IMPEDIMED LIMITED scores 33 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Emerging.
On the Wyckoff cycle it sits in Accumulation, where it has been for 8 trading days. The weekly timeframe reads Downtrend, which does not yet agree with the daily view.
Against the wider market it is currently outperforming and the institutional accumulation signal reads low.
What stands out
- RSI in healthy zone (55)
Points to watch
- 60d drawdown -33.3%
- High volatility (ATR 16.7%)
- Thin liquidity
- Risk rating: Very High
- Composite downside risk elevated
IPD announcements
Recent price-sensitive releases.
- 2026-08-27 Appendix 4E Preliminary Final Report
- 2026-07-28 Quarterly Activities Report and Appendix 4C - Jun-2026 Qtr Commitments Test Entity - Fourth Quarter Activity Report | Web Cast | Commitments Test Entity - Fourth Quarter Cashflow Report
- 2026-06-10 Oversubscribed Share Purchase Plan Successfully Completed
- 2026-06-02 CEO Business Update
- 2026-05-04 ImpediMed announces a successful $15.2 million Capital Raise
- 2026-05-04 Equity Raising Investor Presentation
- 2026-04-30 Trading Halt
More Health Care stocks
Most traded in the same sector.